Article Sidebar

Submitted
September 1, 2022
Accepted
November 30, 2022
Published
December 22, 2022
Download
PDF
Statistic
Read Counter : 228 Download : 193

Main Article Content

Abstract

Vaccination is one of the efforts to prevent and overcome the Covid-19 pandemic. Currently, vaccination can be given to adolescents aged 12-17 years. Vaccines used in national programs are declared safe and effective, but there is no one type of vaccine that is guaranteed to be free of effects or Post Immunization Adverse Events (AEFI). This study was to determine the description of the incidence of post-covid-19 immunization in adolescents. This research is quantitative research with a descriptive research design. This research was conducted at SMPN 37 Pekanbaru City with 100 samples taken using a random sampling method. The analysis used is univariate analysis. The result most of the respondents were 14 years old which found 62 respondents (62%). women with a total of 68 respondents (68%) and men with 32 respondents (32%), class VIII with a total of 17 respondents (17%), and class IX with a total of 83 respondents (83%), all respondents had received the Covid-19 vaccination. 19 doses 1 and 2 with 95 respondents (95%) Sinovac, 4 respondents (4%) Pfizer and 1 respondent (1%) Moderna. The results of the study showed a picture of post-covid-19 vaccination in adolescents, as many as 83 respondents (83%) experienced experiences Adverse Events after Post-Covid-19 Vaccination Immunizations and 13 respondents (13%) did not experience experiences Adverse Events after Post-Covid-19 Vaccination Immunizations. Based on the results of this study, the researcher can conclude that the average student of SMP N 37 Pekanbaru City experiences Adverse Events after Post-Covid-19 Vaccination Immunizations.

Keywords

AEFI adolescents vaccine

Article Details

License

Copyright (c) 2022 Amanda Gabriella, Yufitriana Amir, Sri Utami

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors retain copyright and grant Jurnal Vokasi Keperawatan (JVK)  right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license, that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in jurnal vokasi keperawatan (JVK).
How to Cite
Gabriella, A., Amir, Y., & Utami, S. (2022). Gambaran Kejadian Ikutan Pasca Imunisasi Vaksinasi Covid-19 pada Remaja. Jurnal Vokasi Keperawatan (JVK), 5(2), 119–127. https://doi.org/10.33369/jvk.v5i2.23723
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Aisyiyah, Farida. (2021). Kenali dan awasi Kejadian Ikutan Pasca Imunisasi (KIPI) Covid.19. Diperoleh dari http://dinkes.klatenkab.go.id/promk es/2021/06/11/kenali-dan-awasi-kejadian-ikutan-pasca-imunisasi-kipi/
  2. Kementerian Kesehatan Republik Indonesia (2020). Juknis pelayanan vaksinasi COVID-19. Kementerian Kesehatan Republik Indonesia 2021. kesiapsiagaan menghadapi Covid-19. Diperoleh https://www.kemkes.go.id/folder/view/full-content/structure-faq.html
  3. Dharmayanti, M. (2012). Respon imun terhadap vaksin influenza pada remaja. Kedokteran Brawijaya, 27, 2
  4. Hatmal, Ma’amon. (2021). Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliationVaccines 2021, 9, 556. https://doi.org/10.3390/vaccines9060556
  5. Kemenkes RI. (2020). Pertanyaan dan jawaban terkait Covid-19. Jakarta : Kementerian Kesehatan Republik Indonesia 2020.
  6. Kemenkes RI. (2020). Seputar pelaksanaan vaksinasi Covid-19. Jakarta : Kementerian Kesehatan Republik Indonesia.
  7. Kemenkes RI. (2021). Tujuan vaksinasi Covid-19 pada anak. Jakarta : Kementerian Kesehatan Republik Indonesia.
  8. Rahajeng, K. (2021). Pemerintah kebut vaksinasi Covid-19 bagi lansia dan remaja. Diperoleh dari https://www.cnbcindonesia.com/news/ 20210922155344-4-278317/pemerintah-kebut-vaksinasi-covid-19-bagi-lansia-dan-remaja.
  9. Masturoh, Imas. (2018). Metodologi penelitian kesehatan bahan ajar rekam medis dan informasi kesehatan (RMIK). Kementerian Kesehatan Republik Indonesia.
  10. Mak, J. (2021). Kenapa vaksin Covid-19 menyebabkan efek samping? begini kata ahli. Diperoleh dari https://www.kompas.com/sains/read/2021/06/20/ 080500823/kenapa-vaksin-covid-19-menyebabkan-efek-samping-begini-kata-ahli?page=all.
  11. MK Sari. Jurnal Karya Abdi Masyarakat 4 (1), 80-83, 2020 ... The Indonesian Journal of Health Science 13 (1), 72-81, 2021. 2021.
  12. Maulana, Arif. (2021). Kapan vaksinasi Covid-19 untuk anak di bawah 12 tahun diberikan?. Diperoleh dari https://www.unpad.ac.id/2021/09/kapan-vaksinasi-covid-19-untuk-anak-di-bawah-12-tahun-diberikan/.
  13. Nareza, Meva. (2021). Manfaat vaksin Covid-19 dan kelompok penerima prioritasnya. Diperoleh pada tanggal 25 November 2021 dari https://www.alodokter.com/mengetahui-manfaat-vaksin-covid-19-dan-kelompok-penerima-prioritasnya
  14. Prompetchara, E., Ketloy, C. & Palaga, T. (2020). ‘Immune responses in COVID19 and potential vaccines: Lessons learned from SARS and MERS epidemic’, Asian Pacific journal of allergy and immunology, 38(1), pp. 1–9. doi: 10.12932/AP-200220-0772
  15. Rokom. (2021). Berisiko tinggi alami gejala berat, kemenkes izinkan pemberian vaksinasi COVID-19 pada ibu hamil – sehat negeriku. Diperoleh dari Berisiko Tinggi Alami Gejala Berat, Kemenkes Izinkan Pemberian Vaksinasi COVID-19 Pada Ibu Hamil – Sehat Negeriku (kemkes.go.id)
  16. Sahara, Wahyuni. (2021). 9 Jenis vaksin Covid-19 di Indonesia yang telah dapat izin penggunaan darurat dari BPOM. Diperoleh dari https://nasional.kompas.com/read/2021/ 09/09/09404501/9-jenis- vaksin-covid-19-di-indonesia-yang-telah-dapat-izin-penggunaan?page=all
  17. Soegiarto, Gatot. (2021). Respon imun terhadap vaksin Covid-19 dan komorbid. Diperoleh dari https://rsudrsoetomo.jatimprov.go.id/wpcontent/uploads /2021/01/Respons-imun-terhadap-vaksin-COVID-19-dan-komorbid-sebagai-precaution-Gatot-Soegiarto-2021
  18. Sugiyono. (2017). Metode penelitian kuantitatif, kualitatif, dan R&D. Bandung : Alfabeta, CV.
  19. Sugiyono. (2018). Metode penelitian kombinasi (mixed methods). Bandung: CV Alfabeta
  20. Sun, P. et al. (2020) ‘Understanding of COVID-19 based on current evidence’, Journal of Medical Virology, pp. 0–1. doi: 10.1002/jmv.25722.
  21. Umami,Ida. (2019). Psikologi Remaja. Yogyakarta : Idea Press
  22. Unicef. (2021). Hal-hal yang perlu diketahui sebelum, saat, dan setelah menerima vaksin COVID-19 UNICEF Indonesia. Diperoleh dari https://www.unicef.org/indonesia/id/coronavirus/hal-hal-yang-perlu-diketahui-sebelum-saat-dan-setelah-menerima-vaksin-covid-19
  23. WHO. (2021). Modul 3 – klasifikasi kipi - dasar keamanan vaksin. https://in.vaccine-safety-training.org/classification-of-aefis.html.
  24. World Health Organization (WHO). (2020). Tanda dan Gejala Covid-19. Diperoleh dari https://www.who.int/health-topics/coronavirus#tab=tab_3
  25. World Health Organization (WHO). (2020). Cara penyebaran Covid-19. Diperoleh dari https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted
  26. World Health Organization (WHO). (2020). Cara pencegahan Covid-19. Diperoleh dari https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted
  27. World Health Organization (WHO). (2021). MODUL 3 – Klasifikasi kipi - dasar keamanan vaksin. Diperoleh dari WHO.https://in.vaccine-safety-training.org/classification-of-aefis.html
  28. World Health Organization (WHO). (2014). Health for the world’s adolescents: A second chance in the second decade. Geneva, World Health Organization Departemen of Noncommunicable disease surveillance. (2014).